Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare Biotechnology

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc

Bullboard Posts

Comment by Stylesson Apr 20, 2014 10:20pm

455 Views

Post# 22471133

RE:TSX Listing

all this tsx listing nonsense is b.s.

it won't matter

all that matters in the next few weeks is how the stock will trade given the flood of shares to hit the market. I suspect we could go as low as 5 bucks. layer your bids as 10s of millions of shares are free trade as of friday.

layer your bids!

Bullboard Posts

Showcase Minerals identifies uranium and rare earth elements in Quebec